Why Are More Cancer Patients Talking About Ivermectin?

You may have noticed ivermectin showing up more and more in conversations about cancer, including doctors and patients discussing its off-label use as a repurposed medication.

Posts like the one recently shared by Dr. Christopher Vance highlight how some practitioners are incorporating ivermectin and other repurposed medications into individualized cancer-support approaches.

And the interest isn’t limited to social media. Researchers are now formally studying ivermectin in cancer patients, including a Phase 2 clinical trial evaluating ivermectin alongside immune-checkpoint therapy.

But it’s important to understand where the science stands: Ivermectin is not FDA-approved to treat cancer as clinical trails are need.

Dr. Stella’s approach is supportive—not a replacement for oncology care.

Through Dr. Stella’s telehealth service, patients can get ivermectin & mebendazole as off-label options alongside their existing care.

Continue the treatment plan prescribed by your oncologist.

Do your own research to figure out if this is the right option for you then book a telehealth appointment & the medications.

When you’re fighting cancer, supporting your overall health and immune system matters, but does not replace the treatment plan from your oncologist.

Dr. Stella’s Ultimate Cancer Immune Support is available for those looking to add nutritional and immune support to their wellness routine.

Let's Stay Connected!

DrStellaMD

5207 E 5th St,

Katy TX 77493

(832) 808-5574

www.DrStellaMD.com